US Medical Gas and Equipment Market Size, Growth, Share & Trends Analysis
US Medical Gas and Equipment Market by Type [Medical Gas (Oxygen, Nitrous Oxide), Medical Gas Equipment (Flowmeter, Others)], Application [Therapeutics, Diagnostics], End User [Hospital, Home Healthcare] Forecast to 2031
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The US Medical Gas and Equipment Market, valued at US$8.18 million in 2024, stood at US$8.63 million in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2031, culminating in a forecasted valuation of US$11.97 million by the end of the period. The growth of the medical gas and equipment market in US is primarily driven by the rising incidence of respiratory and chronic diseases, including COPD, asthma, cardiovascular disorders, and sleep apnea, as well as a rapidly aging population that requires long-term oxygen therapy and critical care support. The ongoing upgrading and remodeling of hospital departments, such as intensive care units, operating rooms, and emergency departments, have increased demand for modern medical gas pipeline systems and associated devices. Additionally, the shift toward home healthcare and outpatient care is a key driver of the increased use of portable oxygen concentrators, home oxygen delivery systems, and small gas equipment. Market growth is also supported by innovations in gas generation, monitoring, and safety devices, along with the imposition of strict regulatory standards that enable system upgrades. Moreover, the market is witnessing a significant increase in the application of medical gases in biotechnology, pharmaceutical manufacturing, and diagnostic laboratories, making it one of the most essential parts of the US healthcare ecosystem.
KEY TAKEAWAYS
-
By TypeBy type, the medical gases segment accounted for a larger share of 81.8% of the US medical gas and equipment market in 2024.
-
By ApplicationBy application, in 2024, the therapeutic applications segment accounted for the largest share of the US medical gas and equipment market.
-
By End UserBy end user, the hospitals & clinics segment held the largest share of 63.17% in the US medical gas and equipment market during the forecast period
-
COMPETITIVE LANDSCAPEAir Liquide and Linde Plc were recognized as star players due to their established strong product portfolio.
-
COMPETITIVE LANDSCAPE- STARTUPSCompanies such as NOVAIR USA Corp, among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders
The US medical gas and equipment market growth is largely driven by a rising global burden of chronic respiratory diseases (such as COPD and asthma). Among the key factors driving medical gases and equipment demand in the U. S. are the aging population requiring long, term oxygen therapy and an increasing number of surgical and critical care procedures using anesthetic and respiratory gases. The expansion and modernization of healthcare facilities, increased healthcare spending, and the growing trend of home healthcare by means of portable oxygen concentrators and other respiratory devices, are some of the factors, which, in addition to each other, are enabling demand growth.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The US medical gas and equipment market is changing considerably, influenced by shifts in healthcare delivery models, new technology, and rising patient safety and operational efficiency standards. First, the trends and disruptions affecting customers' customers, such as hospitals, ambulatory surgery centers, specialty clinics, and research institutions, are reshaping how medical gas providers design, deliver, and manage their offerings. Gradually, the market is shifting away from a traditional product-focused revenue model toward an integrated, service-based, and digitally enabled model that provides solutions to clinical, operational, and regulatory imperatives. These changes are aimed at improving patient outcomes, making healthcare workflows more efficient, and ensuring that healthcare systems, which are increasingly in demand, remain stable and sustainable throughout the US.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Rising Prevalence of Respiratory & Chronic Diseases
-
Technological Advancements
Level
-
High capital investment and maintenance costs
-
Complex Regulatory & Compliance Landscape
Level
-
Expansion of healthcare industry
-
Emerging Technologies & Digital Integration
Level
-
Supply Chain & Raw Material Vulnerabilities
-
Workforce & Technical Expertise Gaps
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Rising prevalence of respiratory & chronic diseases
The growing medical gas and equipment market in the US is largely driven by the rising prevalence of respiratory and chronic diseases. These conditions often become the leading causes of long-term respiratory support for patients. Conditions such as chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, cardiovascular disorders, and sleep apnea have dramatically increased the need for medical oxygen, medical air, and related delivery systems in hospitals, clinics, and home care. The elderly population in the US remains a major driver of this demand, as older adults are more vulnerable to chronic respiratory insufficiency and often require oxygen therapy and continuous monitoring. Additionally, the rising number of respiratory emergencies and situations that worsen chronic illnesses is the primary reason medical gas consumption has reached such levels in intensive care units, emergency departments, and during surgical operations. The increased disease burden is, therefore, the leading reason for the rise in medical gas use and the adoption of advanced gas delivery and monitoring equipment across the US healthcare system.
Restraint: High capital investment and maintenance costs
High capital investment and maintenance costs significantly limit the growth of the U.S. medical gas and equipment market, especially among smaller hospitals, outpatient facilities, and rural healthcare providers. The installation of centralized medical gas systems is a major financial investment that requires significant expenditure on bulk storage tanks, manifolds, pipeline infrastructure, alarm systems, and compliance-certified equipment, among other items, all of which must meet strict safety and regulatory standards such as NFPA 99 and FDA requirements. In addition to installation costs, maintenance, periodic inspections, leak testing, calibration, and system upgrades also contribute to long-term operational costs. Moreover, facilities are required to hire qualified technical personnel or third-party service providers to guarantee uninterrupted and safe gas delivery. These high capital and recurring costs can result in postponed system upgrades, restricted adoption of advanced technologies, and budgetary pressure, thus limiting market expansion despite strong clinical demand.
Opportunity: Expansion of healthcare industry
These factors driving the medical gas and equipment market in the US are a direct consequence of the healthcare industry's continuous growth. The US medical gas and equipment market has strong growth potential over the next several years, driven by new capital investments in hospitals, ambulatory surgical centers, specialty clinics, and long-term care facilities. Providers are expanding their facilities primarily to treat chronic diseases and perform surgical procedures, in response to patient demand that continues to rise. As a result, the need for medical gases, gas pipeline systems, and delivery and monitoring equipment is increasing at the same pace. The rise of outpatient facilities and same-day surgical centers is a strong positive factor for the market for small, modular, and economical medical gas systems. Additionally, healthcare infrastructure upgrades and renovation projects focused on safety, efficiency, and compliance with the latest standards have led to the replacement of outdated gas systems with advanced technologies. The continuous growth of healthcare facilities in cities, suburbs, and underserved areas is a source of long-term demand and, hence, creates enormous opportunities for manufacturers and service providers in the US medical gas and equipment market.
Challenge: Supply Chain & Raw Material Vulnerabilities
Supply chain issues and raw material vulnerabilities are major obstacles for US medical gas and equipment markets. The production and distribution of medical gases and related systems require a complex, highly regulated supply network. Medical gases such as oxygen, nitrogen, helium, and nitrous oxide rely on specialized infrastructure for sourcing, purification, storage, and transportation, making them sensitive to disruptions in raw material availability, energy prices, and logistics. Shortages of specialty gases, mainly helium, and dependence on imports for components such as valves, sensors, and electronic controls can cause prices to fluctuate and delivery to be delayed. Such disruptions can hamper hospitals' ability to ensure a continuous supply of gases, especially during periods of high demand or emergencies. As a consequence, suppliers and healthcare facilities are bearing the brunt of increased pressure to improve inventory management, diversify sourcing, and adopt on-site gas generation systems to mitigate supply-related risks.
US MEDICAL GAS AND EQUIPMENT MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Air?????? Liquide offers high-purity medical gases such as oxygen, nitrogen, nitrous oxide, and medical air that are used in hospitals, clinics, and home healthcare facilities. These gases are required for respiratory therapy, anesthesia delivery, intensive care, emergency medicine, and diagnostic procedures. The company also provides support for integrated gas pipeline systems and bulk/packaged supply solutions to ensure uninterrupted availability. | Pure medical gases are the means to patient safety and clinical effectiveness as they comply with strict pharmacopeial and regulatory standards. A dependable oxygen supply is the basis of both acute and chronic respiratory care, while medical air and nitrogen are used to ensure that medical devices operate safely. Continuity in gas quality and supply alleviate clinical risks, elevate patient outcomes, and increase the hospital's operational ??????efficiency. |
 |
Linde?????? offers medical gas mixtures of speciality like one of the components in the mixture is Helium. This mixture is called Heliox. Respiratory care patients suffering from asthma, COPD, and upper airway obstruction are the main users of Heliox. In ICUs, emergency departments, and neonatal care units, Heliox is used to minimize airway resistance and facilitate breathing. | Heliox has a flow capacity that is better than that of the air or oxygen separately, since it is of a lower density. Consequently, the device can relieve respiratory distress, promote patient comfort, and potentially lessen the necessity for invasive ventilation. Also, its application is instrumental in the rapid stabilization of patients and thus, great productivity in the acute and critical respiratory care settings is ??????achieved. |
 |
Taiyo?????? Nippon Sanso provides medical cryogenic gases including liquid oxygen, liquid nitrogen, and liquid carbon dioxide that are used for bulk hospital storage, cryosurgery, biological sample preservation, and medical research. These cryogens are the main components of large healthcare facilities, blood banks, laboratories, and biopharmaceutical applications. | Cryogenic solutions provide very high-volume, low-cost gas storage with stable purity and temperature that can be controlled. Liquid oxygen is used to ensure the supply is uninterrupted in high-demand hospital environments, and liquid nitrogen is used for long-term storage of biological samples and for advanced medical procedures. Thus hospital reliability is enhanced, research continuity is supported, and the overall care delivery efficiency is ??????improved. |
 |
Air?????? Products provides cryogenic products and storage systems that are specifically designed for healthcare and life sciences applications. This includes liquid oxygen systems for hospitals and cryogenic solutions for pharmaceutical manufacturing and laboratory use. Their equipment is capable of supporting the storage, vaporization, and distribution of medical gases in a safe manner. | Cryogenic systems can ensure the secure handling of gases as well as provide continuous availability of these gases even during times of peak demand. The high degree of system reliability that is available most of the time therefore, contributes to a decrease in the risk of system downtime and in turn, patient safety is promoted in critical care environments. Besides, effective cryogenic healthcare technology can also help to cut operational costs while at the same time making it easier to comply with safety and quality standards in healthcare ??????institutions. |
 |
Atlas???????????? Copco provides medical-grade air and gas compressors, which are the main devices used to deliver medical air and support gas pipeline systems in hospitals and clinics. Such compressors are the most necessary ventilators, anesthesia machines, surgical tools, and other pneumatic medical equipment. | Medical air compressors are the sources of clean, oil-free, and contaminant-free air that complies with healthcare standards. Their reliability ensures the uninterrupted operation of life-supporting devices, thus, maintenance requirements are lowered, and energy-saving is increased. As a result, this contributes to patient safety, makes hospital administration easier and the hospital's operational costs are reduced in the long ????????????run. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
In the US, the medical gases and equipment business is central to the overall healthcare delivery system; it is directly responsible for most clinical healthcare applications. This industry also includes some of the leading players in the global industry, such as Air Liquide, Linde, Messer, Taiyo Nippon Sanso, Atlas Copco, and Air Products; these companies are supported by service providers in the form of distributors. Hospitals, clinics, and specialty care facilities are the primary users of the products and services offered in this market, which is driven by the highly developed healthcare infrastructure and the large volume of procedures performed in the country. Regulatory bodies such as the US Food and Drug Administration (FDA), the National Fire Protection Association (NFPA), and UL Solutions closely oversee this market, ensuring that it remains safe, of high quality, and compliant with strict emf guidelines. This makes the US market mature yet still growing at an accelerating pace, driven by advances in technology, renovations, and growing demand for efficient medical gas distribution systems.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
US Medical Gas and Equipment Market, By Type
Medical gases held the largest share of the type segment in the US medical gas and equipment market, mainly because of their vital role in clinical care for almost all healthcare settings. Some of these gases are medical oxygen, nitrous oxide, medical air, nitrogen, and carbon dioxide, which are used continuously in hospitals, emergency departments, intensive care units, operating rooms, and ambulatory surgical centers, thus making them products with a high volume and recurring demand. Of these, medical oxygen is the leading use in respiratory therapy, anesthesia, emergency care, and the treatment of chronic respiratory and cardiovascular diseases, which is why it is so dominant. Medical gases are needed regularly; thus, they are the main driver of revenue, unlike equipment used for one-time or periodic capital purchases. Moreover, the growing home healthcare services and the increased consumption of gases in diagnostic imaging, laboratories, and pharmaceutical applications are two additional factors that have contributed to medical gases holding the largest market share in the US.
US Medical Gas and Equipment Market, By Application
The therapeutic use segment was the major contributor to the US medical gas and equipment market share. This is because medical gases are still extensively and very often used in the care and treatment of both the acute and chronic stages of diseases. Respiratory therapy for patients with various medical conditions, such as COPD, asthma, pneumonia, and cardiovascular disorders that result in low oxygen saturation, is therefore the principal consumer of therapeutic gases, especially oxygen. It is consequent that the rise in the prevalence of chronic diseases, the increase in the elderly population, and hospital admissions have caused the demand for long-term oxygen therapy, intensive care support, and life-saving breathing emergency interventions to increase substantially. In addition, hospitals and the growing home healthcare and outpatient treatment settings have boosted demand for therapeutic gas delivery systems and equipment. The fundamental nature of therapeutic applications, combined with their high frequency and recurrence, has made this segment the largest shareholder in the US medical gas and equipment market.
US Medical Gas and Equipment Market, By End User
The US medical gas and equipment market by end user was dominated by hospitals and clinics. The widespread use in hospitals and clinics reflects their primary role in providing acute, chronic, and surgical care, which requires substantial use of medical gases. Hospitals are the biggest consumers of oxygen, medical air, nitrous oxide, nitrogen, and carbon dioxide, which are primarily used in the intensive care unit, operating theatre, emergency department, and post-operative recovery rooms. Clinics and specialty healthcare centers are other users who rely extensively on medical gas. The enormous patient flow, rising incidence of surgery, and the intensifying prevalence of chronic and respiratory disorders create an endless market for a functional gas delivery system and equipment in these healthcare institutions. In addition, hospitals and clinics, due to stringent regulatory norms, are compelled to implement more advanced medical gas pipeline solutions and monitoring systems, thereby solidifying their position as market leaders in the US medical gas market.
US MEDICAL GAS AND EQUIPMENT MARKET: COMPANY EVALUATION MATRIX
In the US medical gas and equipment market matrix, Air Liquide (France) (Star) and Linde Plc (Germany) (Star) lead with their unmatched global presence, strong brand recognition, and comprehensive portfolios of Medical Gas and Equipment products. Atlas Copco AB (Sweden) (Emerging Leader) is rapidly gaining traction with its versatile products, which offer Medical Gas and Equipment products for various therapeutic and diagnostic applications.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Air Liquide (France)
- Linde Plc (Germany)
- Taiyo Nippon Sanso Corporation (Japan)
- Air Products and Chemicals Inc. (US)
- Atlas Copco AB (Sweden)
- GCE Group (Sweden)
- Messer SE & Co. KGaA (Germany)
- Rotarex (Europe)
- Norco Inc (US)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size Value in 2025 | USD 8637.7 Million |
| Revenue Forecast in 2031 | USD 11978.4 Million |
| Growth Rate | CAGR of 5.6% from 2025-2031 |
| Actual data | 2024-2031 |
| Base year | 2024 |
| Forecast period | 2025-2031 |
| Units considered | Value (USD Million), Volume (Thousands Units) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
|
WHAT IS IN IT FOR YOU: US MEDICAL GAS AND EQUIPMENT MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Volume Analysis | Market assessment by volume (units) for dental equipments used in digital dentures ecosystem |
|
| Product Analysis | Further breakdown of other applications in the market | Insights on other applications involved in the market |
| Company Information | Market Share Analysis, By Country (US) & Competitive Leadership Mapping for Established Players in the market | Insights on market share analysis by country |
RECENT DEVELOPMENTS
- June 2024 : Messer Americas successfully completed its purchase of the Federal Helium System from the U.S. Bureau of Land Management (BLM), marking the transition of this critical national resource from federal to private ownership. The Federal Helium System comprising the Federal Helium Reserve, the Cliffside Field and wells, the 423 mile crude helium pipeline, and related operational assets has historically played a central role in helium supply for sectors including healthcare (eg, MRI machines and breathing gas mixtures), research, aerospace, and manufacturing.
- May 2021 : Atlas Copco acquired the operating assets of Medigas Service & Testing Co. Inc., a New York–based supplier specializing in the service, verification, installation, and sales of piped medical and laboratory gas systems. Medigas, a privately owned company and an authorized BeaconMedaes representative, brought strong regional expertise and an established customer base across healthcare and laboratory facilities in the US.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Methodology
This study involved four major activities in estimating the current US medical gas and equipment market size. Exhaustive secondary research was done to collect information on the market, peer market and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
Secondary Research
The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the prefilled syringes market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the US medical gas and equipment market. The primary sources from the demand side included industry experts, purchase & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.
To know about the assumptions considered for the study, download the pdf brochure
The research methodology used to estimate the size of the market includes the following details.
The market sizing of the market was undertaken from the global side.
Country-level Analysis: The size of the US medical gas and equipment was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products and services in the overall US medical gas and equipment market was obtained from secondary data and validated by primary participants to arrive at the total US medical gas and equipment market. Primary participants further validated the numbers.
Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by US medical gas and equipment and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall US medical gas and equipment and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
Data Triangulation
After arriving at the overall market size—using the market size estimation processes explained above—the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Medical gases and equipment are significant elements in medical centers (such as acute care, hospitals, surgery centers, and emergency medical services), life sciences (pharmaceutical, biotech, and life science R&D), long-term care (like nursing homes and home healthcare), and laboratories (including analytical, commercial, life sciences, and university laboratories). The market covers medical pure gases, medical gas mixtures, and various equipment used for the storage, transportation, and delivery of medical gases.
Key Stakeholders
- Medical gas manufacturers
- Medical gases equipment manufacturing companies
- Medical gases and equipment distributors
- Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)
- Pharmaceutical and biotechnology companies
- Research institutes and academic centers
- Contract research organizations (CROs)
- Government associations
- Home-healthcare services providers
- Market research and consulting firms
- Venture capitalists and investors
Objectives of the Study
- To describe, analyze, and forecast the US medical gas and equipment market by type, application, end user and region
- To describe and forecast the US medical gas and equipment market for key regions—North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
- To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the growth of the US medical gas and equipment market
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To profile key players and comprehensively analyze their market shares and core competencies2 in the US medical gas and equipment market
- To analyze competitive developments such as partnerships, collaborations, agreements & acquisitions, product launches, expansions, and R&D activities in the US medical gas and equipment market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographic Analysis
- Further breakdown of the Rest of Europe US medical gas and equipment market into Belgium, Russia, the Netherlands, Switzerland, and other countries.
- Further breakdown of the Rest of Asia Pacific US medical gas and equipment market into Indonesia, Philippines, Vietnam, Hong Kong, and other countries
- Further breakdown of the Rest of Latin America US medical gas and equipment into Colombia, Peru, and other countries.
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This ReportPersonalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the US Medical Gas and Equipment Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Growth opportunities and latent adjacency in US Medical Gas and Equipment Market